Top

Neurological Sciences

Published in:

Open Access 01-03-2019 | Original Article

Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients

Authors: Gang Cheng, Jianning Zhang

Published in: Neurological Sciences | Issue 3/2019

Abstract

Background

Because of the low incidence of primary central nervous system lymphoma (PCNSL) in non-HIV individuals and because of the lack of specific clinical manifestations and auxiliary examinations, the disease is easily missed or misdiagnosed.

Objective

To analyze the imaging features of PCNSL in non-HIV patients.

Methods

This was a retrospective study of patients with PCNSL treated between January 2001 and December 2011 at the Naval General Hospital (Beijing, China). All included patients were pathologically diagnosed with PCNSL. Specimens were obtained by stereotactic biopsy and diagnosed by pathological examination. Serological panel had to be negative for HIV.

Results

Out of the 118 patients, 73 (61.9%) were male and 45 (38.1%) were female. Median age was 54 (range 11–83) years. All patients had B cell lymphoma. The lesions showed slightly hyperintense shadows on computed tomography (CT) images, and mostly hyperintense T1 and iso- or hyperintense T2 signals on magnetic resonance imaging (MRI). Most lesions showed patchy enhancement after enhanced scanning, and some had the characteristic “butterfly sign” on enhanced MRI. The magnetic resonance spectroscopy of PCNSL manifested as increased Cho peak, moderately decreased NAA peak, and slightly decreased Cr peak. Positron emission computed tomography indicated high metabolism of ¹⁸F-FDG in PCNSL lesions.

Conclusion

MRI is important in the diagnosis of PCNSL. Understanding the imaging features of PCNSL will help improve its diagnosis in clinics.

Hochberg FH, Baehring JM, Hochberg EP (2007) Primary CNS lymphoma. Nat Clin Pract Neurol 3(1):24–35. https://doi.org/10.1038/ncpneuro0395 CrossRefPubMed

Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A (2007) Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003: time trends in a 15-year national survey. Cancer 110(8):1803–1814. https://doi.org/10.1002/cncr.22989 CrossRefPubMed

Algazi AP, Kadoch C, Rubenstein JL (2009) Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics 6(3):587–597. https://doi.org/10.1016/j.nurt.2009.04.013 CrossRefPubMedPubMedCentral

Fraser E, Gruenberg K, Rubenstein JL (2015) New approaches in primary central nervous system lymphoma. Chin Clin Oncol 4(1):11. https://doi.org/10.3978/j.issn.2304-3865.2015.02.01 CrossRefPubMedPubMedCentral

Latta S, Myint ZW, Jallad B, Hamdi T, Alhosaini MN, Kumar DV, Kheir F (2010) Primary central nervous system T-cell lymphoma in aids patients: case report and literature review. Curr Oncol 17(5):63–66CrossRefPubMedPubMedCentral

Gonzalez-Aguilar A, Soto-Hernandez JL (2011) The management of primary central nervous system lymphoma related to AIDS in the HAART era. Curr Opin Oncol 23(6):648–653. https://doi.org/10.1097/CCO.0b013e32834b6adc CrossRefPubMed

Kasamon YL, Ambinder RF (2005) AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am 19(4):665–687, vi-vii. https://doi.org/10.1016/j.hoc.2005.05.004 CrossRefPubMed

Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA (2014) MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 14(22):1–9. https://doi.org/10.1186/1470-7330-14-22 CrossRef

Kuker W, Nagele T, Korfel A, Heckl S, Thiel E, Bamberg M, Weller M, Herrlinger U (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neuro-Oncol 72(2):169–177. https://doi.org/10.1007/s11060-004-3390-7 CrossRef

10.

Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z (2009) Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 50(2):217–225. https://doi.org/10.1080/02841850802616752 CrossRefPubMed

11.

Ferreri AJ, Abrey LE, Blay JY, Borisch B, Hochman J, Neuwelt EA, Yahalom J, Zucca E, Cavalli F, Armitage J, Batchelor T (2003) Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 21(12):2407–2414. https://doi.org/10.1200/JCO.2003.01.135 CrossRefPubMed

12.

Zacharia TT, Law M, Naidich TP, Leeds NE (2008) Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging 18(4):411–417. https://doi.org/10.1111/j.1552-6569.2007.00231.x CrossRefPubMed

13.

Tang YZ, Booth TC, Bhogal P, Malhotra A, Wilhelm T (2011) Imaging of primary central nervous system lymphoma. Clin Radiol 66(8):768–777. https://doi.org/10.1016/j.crad.2011.03.006 CrossRefPubMed

14.

Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12(2):329–340. https://doi.org/10.1007/s003300101037 CrossRefPubMed

15.

Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62(10):1595–1600. https://doi.org/10.1001/archneur.62.10.1595 CrossRefPubMed

16.

Qian L, Zhou C, Shen J, Cen J, Yin W (2016) Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy. Oncotarget 7(18):25783–25790. https://doi.org/10.18632/oncotarget.8370 CrossRefPubMedPubMedCentral

17.

Haldorsen IS, Krakenes J, Krossnes BK, Mella O, Espeland A (2009) CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 30(4):744–751. https://doi.org/10.3174/ajnr.A1447 CrossRefPubMed

18.

Schramm P, Xyda A, Klotz E, Tronnier V, Knauth M, Hartmann M (2010) Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 20(10):2482–2490. https://doi.org/10.1007/s00330-010-1817-4 CrossRefPubMedPubMedCentral

19.

Haldorsen IS, Espeland A, Larsson EM (2011) Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 32(6):984–992. https://doi.org/10.3174/ajnr.A2171 CrossRefPubMed

20.

Zhang D, Hu LB, Henning TD, Ravarani EM, Zou LG, Feng XY, Wang WX, Wen L (2010) MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol 11(3):269–277. https://doi.org/10.3348/kjr.2010.11.3.269 CrossRefPubMedPubMedCentral

21.

Eichler AF, Batchelor TT (2006) Primary central nervous system lymphoma: presentation, diagnosis and staging. Neurosurg Focus 21(5):E15CrossRefPubMed

22.

White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjornerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM (2014) Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res 74(17):4638–4652. https://doi.org/10.1158/0008-5472.CAN-13-3534 CrossRefPubMedPubMedCentral

23.

Barajas RF Jr, Rubenstein JL, Chang JS, Hwang J, Cha S (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 31(1):60–66. https://doi.org/10.3174/ajnr.A1750 CrossRefPubMed

24.

Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224(1):177–183. https://doi.org/10.1148/radiol.2241010637 CrossRefPubMed

25.

Horger M, Fenchel M, Nagele T, Moehle R, Claussen CD, Beschorner R, Ernemann U (2009) Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum. AJR Am J Roentgenol 193(5):1384–1387. https://doi.org/10.2214/AJR.09.2486 CrossRefPubMed

26.

Soares DP, Law M (2009) Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 64(1):12–21. https://doi.org/10.1016/j.crad.2008.07.002 CrossRefPubMed

27.

Verma A, Kumar I, Verma N, Aggarwal P, Ojha R (2016) Magnetic resonance spectroscopy - revisiting the biochemical and molecular milieu of brain tumors. BBA Clin 5:170–178. https://doi.org/10.1016/j.bbacli.2016.04.002 CrossRefPubMedPubMedCentral

28.

Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342(3):163–166CrossRefPubMed

29.

Raizer JJ, Koutcher JA, Abrey LE, Panageas KS, DeAngelis LM, Lis E, Xu S, Zakian KL (2005) Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J Neuro-Oncol 71(2):173–180. https://doi.org/10.1007/s11060-004-1360-8 CrossRef

30.

Bizzi A, Movsas B, Tedeschi G, Phillips CL, Okunieff P, Alger JR, Di Chiro G (1995) Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 194(1):271–276. https://doi.org/10.1148/radiology.194.1.7997566 CrossRefPubMed

31.

Karantanis D, O'Eill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Lowe VJ, Peller PJ, Wiseman GA (2007) 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun 28(11):834–841. https://doi.org/10.1097/MNM.0b013e328264ae7f CrossRefPubMed

32.

Zou Y, Tong J, Leng H, Jiang J, Pan M, Chen Z (2017) Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: a systematic review and meta-analysis. Oncotarget 8(25):41518–41528. https://doi.org/10.18632/oncotarget.17456 CrossRefPubMedPubMedCentral

33.

Palmedo H, Urbach H, Bender H, Schlegel U, Schmidt-Wolf IG, Matthies A, Linnebank M, Joe A, Bucerius J, Biersack HJ, Pels H (2006) FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging 33(2):164–168. https://doi.org/10.1007/s00259-005-1917-6 CrossRefPubMed

34.

Berti V, Mosconi L, Pupi A (2014) Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. PET Clin 9(2):129–140. https://doi.org/10.1016/j.cpet.2013.10.006 CrossRefPubMed

35.

Kawai N, Okubo S, Miyake K, Maeda Y, Yamamoto Y, Nishiyama Y, Tamiya T (2010) Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Ann Nucl Med 24(5):335–343. https://doi.org/10.1007/s12149-010-0356-z CrossRefPubMed

Title: Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients
Authors: Gang Cheng
Jianning Zhang
Publication date: 01-03-2019
Publisher: Springer International Publishing
Published in: Neurological Sciences / Issue 3/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-018-3669-7

At a glance: The STEP trials

Springer Medicine

Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients

Abstract

Background

Objective

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2019

Regression-based normative data and equivalent scores for Trail Making Test (TMT): an updated Italian normative study

Task-specific focal chin tremor in idiopathic Parkinson’s disease: is it an isolated phenomenon or a part of parkinsonism?

Red Flags for early referral of people with symptoms suggestive of narcolepsy: a report from a national multidisciplinary panel

The clinical and imaging features of gray matter heterotopia: a clinical analysis on 15 patients

Clinical and genetic characterization of an Italian family with slow-channel syndrome

Italian recommendations for diagnosis and management of congenital myasthenic syndromes